VEGFA and breast carcinoma: Moreover, dual silencing of VEGFA in cancer cells and VEGFR1 in endothelial cells significantly suppressed VM formation in breast cancer, suggesting that codelivery of multiple siRNAs is a promising strategy to improve the anti-angiogenetic effects [261].